6:00 p.m. CET – In accordance with the provisions of article L.233-8 II of the French Commercial Code and article 223-16 of the General Regulations of the Autorité des Marchés Financiers (“AMF”). ADOCIA SA, 115, avenue Lacassagne, 69003 Lyon (Euronext Paris: FR0011184241 – ADOC – the “Company”), a biopharmaceutical company specializing in the treatment of diabetes, obesity and other metabolic diseases using innovative formulations of approved proteins , publishes the number of shares making up its share capital as well as the number of associated voting rights as of December 31, 2021.